NASDAQ:SMMT

Summit Therapeutics Stock Forecast

etoro logo Buy SMMT
*Your capital is at risk
$14.77
-0.0700 (-0.472%)
At Close: Jun 05, 2026
AI Analysis AI Analysis of SMMT AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add SMMT to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Friday for Summit Therapeutics plc
(Updated on Jun 05, 2026)

Sell candidate since Jun 01, 2026 Loss -5.98%

The Summit Therapeutics plc stock price fell by -0.472% on the last day (Friday, 5th Jun 2026) from $14.84 to $14.77. During the last trading day the stock fluctuated 4.64% from a day low at $14.66 to a day high of $15.34. The price has been going up and down for this period, and there has been a -15.46% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -5 million shares and in total, 0 shares were bought and sold for approximately $0 .

The stock has broken the very wide and horizontal trend down. Breaks like this are often followed by swift and strong movements, and any correction down to the breakline at approximately $15.57 is considered to be a "second chance" to get out before further fall. It is, however, important to note that false breaks may appear and that the price may move back into the horizontal trend. A break on increasing volume is considered to be more significant and reliable than breaks on low volume.

SMMT Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Summit Therapeutics plc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $15.74 and $18.71. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, May 29, 2026, and so far it has fallen -15.79%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Summit Therapeutics plc stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.680 between high and low, or 4.64%. For the last week the stock has had daily average volatility of 7.34%

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (SMMT) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Summit Therapeutics plc to open at $14.92, and during the day (based on 14 day Average True Range), to move between $14.14 and $15.40, which gives a possible trading interval of +/-$1.25 (+/-8.87%) up or down from last closing price. If Summit Therapeutics plc takes out the full calculated possible swing range there will be an estimated 8.87% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $15.71, some $0.94 (6.36%) from the current price of $14.77, our system finds the risk reward not very attractive.

Is Summit Therapeutics plc stock A Buy?

Summit Therapeutics plc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.804 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $14.92 ( 1.04%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

SMMT Performance

Trading levels for SMMT

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 15.60 5.64%
R2 15.34 3.88%
R1 15.18 2.80%
Price 14.77
S1 14.66 -0.721%
S2 14.50 -1.81%
S3 14.24 -3.57%

Accumulated Volume Support & Resistance Levels

Level Price
R3 17.54 18.75%
R2 16.12 9.11%
R1 15.71 6.36%
Price 14.77
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Summit Therapeutics plc Stock and on which exchange is it traded?
The symbol for Summit Therapeutics plc is SMMT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Summit Therapeutics plc Stock?
Summit Therapeutics plc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Summit Therapeutics plc Stock?
Summit Therapeutics plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Summit Therapeutics plc Stock.

What's the current price of Summit Therapeutics plc Stock?
As of the end of day on the Jun 05, 2026, the price of an Summit Therapeutics plc (SMMT) share was $14.77.

What is the 52-week high and low for Summit Therapeutics plc Stock?
The 52-week high for Summit Therapeutics plc Stock is $30.98 and the 52-week low is $13.83.

What is the market capitalization of Summit Therapeutics plc Stock?
As of the Jun 05, 2026, the market capitalization of Summit Therapeutics plc is 11.452B.

When is the next earnings date for Summit Therapeutics plc?
The upcoming earnings date for Summit Therapeutics plc is Aug 10, 2026.
Click to get the best stock tips daily for free!
ABOUT SUMMIT THERAPEUTICS PLC
Summit Therapeutics
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, fo...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE